Profile
K.
Chris Min is a former Senior Medical Director-Neurology at Bluerock Therapeutics, Inc. and a former VP, Head-Medical & Clinical Development at Enterin, Inc. In 2023, he served as the Chief Medical Officer at Longeveron, Inc. Dr. Min holds an undergraduate degree from Harvard University and doctorate degrees from The Rockefeller University and Weill Cornell Medical College.
Former positions of K. Min
| Companies | Position | End |
|---|---|---|
| LONGEVERON INC. | Chief Executive Officer | 2023-02-28 |
Enterin, Inc.
 Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Chief Tech/Sci/R&D Officer | 2021-03-31 |
| Bluerock Therapeutics, Inc. | Corporate Officer/Principal | - |
Training of K. Min
| Weill Cornell Medical College | Doctorate Degree |
| The Rockefeller University | Doctorate Degree |
| Harvard University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LONGEVERON INC. | Health Technology |
| Private companies | 2 |
|---|---|
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Health Technology |
| Bluerock Therapeutics, Inc. |
- Stock Market
- Insiders
- K. Min
